Cytodyme

About Cytodyme

Cytodyme offers a rapid onboarding software platform that automates the generation of cGMP-compliant batch records and connects biotech innovators with suitable Contract Development Manufacturing Organizations (CDMOs). This technology reduces the time and complexity involved in translating research processes to clinical manufacturing, enabling faster development of life-saving therapies.

```xml <problem> Translating research processes into cGMP-compliant manufacturing procedures is a time-consuming and complex bottleneck for biotech companies and academic labs developing cell and gene therapies. Identifying and onboarding with a suitable Contract Development Manufacturing Organization (CDMO) further delays the clinical development timeline. </problem> <solution> Cytodyme offers a software platform designed to accelerate the clinical translation of cell and gene therapies. The platform automates the generation of cGMP-compliant batch records from user-defined processes, significantly reducing the time required for process documentation. Cytodyme also connects biotech innovators with appropriate CDMOs, streamlining the selection and onboarding process. By automating batch record generation and facilitating CDMO partnerships, Cytodyme aims to reduce bottlenecks and inefficiencies in clinical development, enabling faster delivery of personalized therapies. </solution> <features> - Automated generation of cGMP-compliant batch records from user-defined process inputs. - Intuitive software interface designed for ease of use and rapid process translation. - Matching algorithm to connect biotech innovators with suitable CDMO partners based on specific needs and capabilities. - Secure, local data storage of process information. - Streamlined communication and collaboration tools for innovators and CDMOs. </features> <target_audience> The primary target audience includes small to mid-sized biotech companies and academic labs involved in cell and gene therapy development. </target_audience> ```

What does Cytodyme do?

Cytodyme offers a rapid onboarding software platform that automates the generation of cGMP-compliant batch records and connects biotech innovators with suitable Contract Development Manufacturing Organizations (CDMOs). This technology reduces the time and complexity involved in translating research processes to clinical manufacturing, enabling faster development of life-saving therapies.

Where is Cytodyme located?

Cytodyme is based in San Diego, United States.

When was Cytodyme founded?

Cytodyme was founded in 2024.

Who founded Cytodyme?

Cytodyme was founded by Dennis White.

  • Dennis White - CEO/Co-founder
Location
San Diego, United States
Founded
2024
Employees
2 employees
Looking for specific startups?
Try our free semantic startup search

Cytodyme

Score: 48/100
AI-Generated Company Overview (experimental) – could contain errors

Executive Summary

Cytodyme offers a rapid onboarding software platform that automates the generation of cGMP-compliant batch records and connects biotech innovators with suitable Contract Development Manufacturing Organizations (CDMOs). This technology reduces the time and complexity involved in translating research processes to clinical manufacturing, enabling faster development of life-saving therapies.

cytodyme.com100+
Founded 2024San Diego, United States

Funding

No funding information available. Click "Fetch funding" to run a targeted funding scan.

Team (<5)

Dennis White

CEO/Co-founder

Company Description

Problem

Translating research processes into cGMP-compliant manufacturing procedures is a time-consuming and complex bottleneck for biotech companies and academic labs developing cell and gene therapies. Identifying and onboarding with a suitable Contract Development Manufacturing Organization (CDMO) further delays the clinical development timeline.

Solution

Cytodyme offers a software platform designed to accelerate the clinical translation of cell and gene therapies. The platform automates the generation of cGMP-compliant batch records from user-defined processes, significantly reducing the time required for process documentation. Cytodyme also connects biotech innovators with appropriate CDMOs, streamlining the selection and onboarding process. By automating batch record generation and facilitating CDMO partnerships, Cytodyme aims to reduce bottlenecks and inefficiencies in clinical development, enabling faster delivery of personalized therapies.

Features

Automated generation of cGMP-compliant batch records from user-defined process inputs.

Intuitive software interface designed for ease of use and rapid process translation.

Matching algorithm to connect biotech innovators with suitable CDMO partners based on specific needs and capabilities.

Secure, local data storage of process information.

Streamlined communication and collaboration tools for innovators and CDMOs.

Target Audience

The primary target audience includes small to mid-sized biotech companies and academic labs involved in cell and gene therapy development.

Cytodyme | StartupSeeker